203 related articles for article (PubMed ID: 33248684)
1. Factors associated with physicians' recommendations for managing low-risk papillary thyroid cancer.
McDow AD; Roman BR; Saucke MC; Jensen CB; Zaborek N; Jennings JL; Davies L; Brito JP; Pitt SC
Am J Surg; 2021 Jul; 222(1):111-118. PubMed ID: 33248684
[TBL] [Abstract][Full Text] [Related]
2. Adoption of Active Surveillance for Very Low-Risk Differentiated Thyroid Cancer in the United States: A National Survey.
Pitt SC; Yang N; Saucke MC; Marka N; Hanlon B; Long KL; McDow AD; Brito JP; Roman BR
J Clin Endocrinol Metab; 2021 Mar; 106(4):e1728-e1737. PubMed ID: 33373458
[TBL] [Abstract][Full Text] [Related]
3. Trends and Outcomes of Surgical Management of Primary Papillary Carcinoma in the Pediatric Population.
Sharma RK; Huang B; Lee JA; Kuo JH
J Surg Res; 2021 Jul; 263():207-214. PubMed ID: 33690052
[TBL] [Abstract][Full Text] [Related]
4. GAUGING THE EXTENT OF THYROIDECTOMY FOR INDETERMINATE THYROID NODULES: AN ONCOLOGIC PERSPECTIVE.
Schneider DF; Cherney Stafford LM; Brys N; Greenberg CC; Balentine CJ; Elfenbein DM; Pitt SC
Endocr Pract; 2017 Apr; 23(4):442-450. PubMed ID: 28095042
[TBL] [Abstract][Full Text] [Related]
5. Understanding surgical decision-making in older adults with differentiated thyroid cancer: A discrete choice experiment.
Sutton W; Genberg B; Prescott JD; Segev DL; Zeiger MA; Bandeen-Roche K; Mathur A
Surgery; 2021 Jan; 169(1):14-21. PubMed ID: 32475718
[TBL] [Abstract][Full Text] [Related]
6. Thyroid lobectomy as a cost-effective approach in low-risk papillary thyroid cancer versus active surveillance.
Youssef MR; Attia AS; Omar M; Aboueisha M; Freeman MN; Shama M; Kandil E
Surgery; 2022 Jan; 171(1):190-196. PubMed ID: 34384606
[TBL] [Abstract][Full Text] [Related]
7. Impact of the American Thyroid Association guidelines on the Australian surgical management of papillary thyroid cancer.
Cole-Clark D; Townend PJ; Engelsman A; Wong MS; Sywak M; Glover A; Sidhu SB
ANZ J Surg; 2018 Nov; 88(11):1102-1103. PubMed ID: 30387282
[No Abstract] [Full Text] [Related]
8. Practice patterns for surgical management of low-risk papillary thyroid cancer from 2014 to 2019: A CESQIP analysis.
Wrenn SM; Wang TS; Toumi A; Kiernan CM; Solórzano CC; Stephen AE
Am J Surg; 2021 Feb; 221(2):448-454. PubMed ID: 32933747
[TBL] [Abstract][Full Text] [Related]
9. NATIONAL SURVEY OF ENDOCRINOLOGISTS AND SURGEONS REGARDING ACTIVE SURVEILLANCE FOR LOW-RISK PAPILLARY THYROID CANCER.
Roman BR; Brito JP; Saucke MC; Lohia S; Jensen CB; Zaborek N; Jennings JL; Tuttle RM; Davies L; Pitt SC
Endocr Pract; 2021 Jan; 27(1):1-7. PubMed ID: 33471727
[TBL] [Abstract][Full Text] [Related]
10. Postoperative Surveillance in Older Adults With T1N0M0 Low-risk Papillary Thyroid Cancer.
Pradhan MC; Kazaure HS; Wang F; Zambeli-Ljepovic A; Perkins JM; Stang MT; Scheri RP
J Surg Res; 2021 Aug; 264():37-44. PubMed ID: 33765509
[TBL] [Abstract][Full Text] [Related]
11. Adherence to ATA 2015 guidelines in the management of unifocal non-invasive papillary thyroid cancer: a clinical survey among endocrinologists and surgeons.
Or K; Benbassat C; Koren S; Shteinshneider M; Koren R; Cantrell D; Kummer E; Muallem Kalmovich L
Eur Arch Otorhinolaryngol; 2018 Nov; 275(11):2851-2859. PubMed ID: 30229453
[TBL] [Abstract][Full Text] [Related]
12. Thyrotropin Suppression for Papillary Thyroid Cancer: A Physician Survey Study.
Papaleontiou M; Chen DW; Banerjee M; Reyes-Gastelum D; Hamilton AS; Ward KC; Haymart MR
Thyroid; 2021 Sep; 31(9):1383-1390. PubMed ID: 33779292
[No Abstract] [Full Text] [Related]
13. Current management of papillary thyroid microcarcinoma in Canada.
Merdad M; Eskander A; De Almeida J; Freeman J; Rotstein L; Ezzat S; Sawka AM; Goldstein DP
J Otolaryngol Head Neck Surg; 2014 Aug; 43(1):32. PubMed ID: 25123954
[TBL] [Abstract][Full Text] [Related]
14. A Prospective Mixed-Methods Study of Decision-Making on Surgery or Active Surveillance for Low-Risk Papillary Thyroid Cancer.
Sawka AM; Ghai S; Yoannidis T; Rotstein L; Gullane PJ; Gilbert RW; Pasternak JD; Brown DH; Eskander A; Almeida JR; Irish JC; Higgins K; Enepekides DJ; Monteiro E; Banerjee A; Shah M; Gooden E; Zahedi A; Korman M; Ezzat S; Jones JM; Rac VE; Tomlinson G; Stanimirovic A; Gafni A; Baxter NN; Goldstein DP
Thyroid; 2020 Jul; 30(7):999-1007. PubMed ID: 32126932
[No Abstract] [Full Text] [Related]
15. A Protocol for a Pan-Canadian Prospective Observational Study on Active Surveillance or Surgery for Very Low Risk Papillary Thyroid Cancer.
Sawka AM; Ghai S; Tomlinson G; Baxter NN; Corsten M; Imran SA; Bissada E; Lebouef R; Audet N; Brassard M; Zhang H; Gupta M; Nichols AC; Morrison D; Johnson-Obeski S; Prisman E; Anderson D; Chandarana SP; Ghaznavi S; Jones J; Gafni A; Matelski JJ; Xu W; Goldstein DP;
Front Endocrinol (Lausanne); 2021; 12():686996. PubMed ID: 34194396
[TBL] [Abstract][Full Text] [Related]
16. REFERRAL OF OLDER THYROID CANCER PATIENTS TO A HIGH-VOLUME SURGEON: RESULTS OF A MULTIDISCIPLINARY PHYSICIAN SURVEY.
Papaleontiou M; Gauger PG; Haymart MR
Endocr Pract; 2017 Jul; 23(7):808-815. PubMed ID: 28534681
[TBL] [Abstract][Full Text] [Related]
17. Radioactive iodine does not improve overall survival for patients with aggressive variants of papillary thyroid carcinoma less than 2 cm.
Holoubek SA; MacKinney EC; Khokar AM; Kuchta KM; Winchester DJ; Prinz RA; Moo-Young TA
Surgery; 2022 Jan; 171(1):203-211. PubMed ID: 34384604
[TBL] [Abstract][Full Text] [Related]
18. Active Surveillance for T1bN0M0 Papillary Thyroid Carcinoma.
Sakai T; Sugitani I; Ebina A; Fukuoka O; Toda K; Mitani H; Yamada K
Thyroid; 2019 Jan; 29(1):59-63. PubMed ID: 30560718
[TBL] [Abstract][Full Text] [Related]
19. Basis for physician recommendations for adjuvant radioiodine therapy in early-stage thyroid carcinoma: principal findings of the Canadian-American thyroid cancer survey.
Sawka AM; Goldstein DP; Thabane L; Brierley JD; Tsang RW; Rotstein L; Kamalanathan S; Zhao B; Gafni A; Straus S; Ezzat S
Endocr Pract; 2008 Mar; 14(2):175-84. PubMed ID: 18308655
[TBL] [Abstract][Full Text] [Related]
20. Low-Risk Thyroid Cancer in Elderly: Total Thyroidectomy/RAI Predominates but Lacks Survival Advantage.
Zambeli-Ljepović A; Wang F; Dinan MA; Hyslop T; Roman SA; Sosa JA; Scheri RP
J Surg Res; 2019 Nov; 243():189-197. PubMed ID: 31185435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
